The potential of synthetic indolylquinoline derivatives for Aβ aggregation reduction by chemical chaperone activity. (February 2016)

• Record Type: Journal Article
• Authors: Chang, Kuo-Hsuan; Chiu, Ya-Jen; Chen, Shu-Ling; Huang, Chen-Hsiang; Lin, Chih-Hsin; Lin, Te-Hsien; Lee, Chi-Mei; Ramesh, Chintakunta; Wu, Chung-Hsin; Huang, Chin-Chang; Fung, Hon-Chung; Chen, Yi-Chun; Lin, Jung-Yaw; Yao, Ching-Fa; Huang, Hei-Jen; Lee-Chen, Guey-Jen; Lee, Ming-Chung; Hsieh-Li, Hsiu Mei
• Is Part Of: Neuropharmacology. Volume 101(2016)
• Page Start: 309
• Page End: 319
• Publication Date: 2016-02
• Subjects: Alzheimer's disease -- Aβ aggregation -- Synthetic indolylquinoline derivatives -- Therapeutics; Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2015.09.005
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: Alzheimer's disease (AD) is the most prevalent form of dementia associated with progressive cognitive decline and memory loss. Extracellular β-amyloid (Aβ) is a major constituent of senile plaques, one of the pathological hallmarks of AD. Aβ deposition causes neuronal death via a number of possible mechanisms such as increasing oxidative stress. Therefore therapeutic approaches to identify novel Aβ aggregate reducers could be effective for AD treatment. Using a Trx-His-Aβ biochemical assay, we screened 11 synthetic indolylquinoline compounds, and found NC009-1, -2, -6 and -7 displaying potential to reduce Aβ aggregation. Treating Tet-On Aβ-GFP 293 cells with these compounds reduced Aβ aggregation and reactive oxygen species. These compounds also promoted neurite outgrowth in Tet-On Aβ-GFP SH-SY5Y cells. Furthermore, treatment with above compounds improved neuronal cell viability, neurite outgrowth, and synaptophysin expression level in mouse hippocampal primary culture under oligomeric Aβ-induced cytotoxicity. Moreover, the tested NC009-1 significantly ameliorated Aβ-induced inhibition of hippocampal long-term potentiation in mouse hippocampal slices. Our results demonstrate how synthetic indolylquinoline compounds are likely to work as chemical chaperones in Aβ-aggregation reduction and neuroprotection, providing insight into the possible applications of indolylquinoline compounds in AD treatment. Highlights: Indolylquinoline compounds work as chemical chaperones in Aβ-aggregation reduction. Indolylquinolines suppress ROS and promote neurite outgrowth in Aβ-expressing cells. Indolylquinolines provide neuroprotection in Aβ-treated mouse hippocampal cells. Indolylquinolines ameliorate Aβ-induced inhibition of LTP in mouse hippocampal slices.